Evidence map›Paper›PMID 36716454›Full record

ArticleAnnals of internal medicine2023

Planning for Mpox on a College Campus: A Model-Based Decision-Support Tool.

Alexandra Savinkina, Melanie Chitwood, Jiye Kwon, Virginia E Pitzer, Gregg Gonsalves, A David Paltiel

Abstract read
In one paragraph

Article in Annals of internal medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alexandra SavinkinaDepartment of Epidemiology of Microbial Diseases and Public Health Modeling Unit, Yale School of Public Health, New Haven, Connecticut (A.S., M.C., J.K., V.E.P., G.G.).ORCID 0000-0002-5257-866X
Melanie ChitwoodDepartment of Epidemiology of Microbial Diseases and Public Health Modeling Unit, Yale School of Public Health, New Haven, Connecticut (A.S., M.C., J.K., V.E.P., G.G.).ORCID 0000-0002-9289-5694
Jiye KwonDepartment of Epidemiology of Microbial Diseases and Public Health Modeling Unit, Yale School of Public Health, New Haven, Connecticut (A.S., M.C., J.K., V.E.P., G.G.).
Virginia E PitzerDepartment of Epidemiology of Microbial Diseases and Public Health Modeling Unit, Yale School of Public Health, New Haven, Connecticut (A.S., M.C., J.K., V.E.P., G.G.).ORCID 0000-0003-1015-2289
Gregg GonsalvesDepartment of Epidemiology of Microbial Diseases and Public Health Modeling Unit, Yale School of Public Health, New Haven, Connecticut (A.S., M.C., J.K., V.E.P., G.G.).ORCID 0000-0002-5789-9841
A David PaltielPublic Health Modeling Unit and Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut (A.D.P.).ORCID 0000-0002-4861-3290

Funding

Making Better Decisions: Policy Modeling for AIDS and Drug AbuseR37DA015612 · NIDA · STANFORD UNIVERSITY · PI DOUGLAS K OWENS · 2019 to 2026
$6.3M
Predicting and monitoring variations in the effects of vaccines against RSVR01AI137093 · NIAID · YALE UNIVERSITY · PI Virginia E Pitzer, Daniel Martin Weinberger · 2018 to 2026
$3.4M
Novel, Adaptive Approaches to Predicting and Responding to Outbreaks of Overdose, HIV and HCV Among People Who Use DrugsDP2DA049282 · NIDA · YALE UNIVERSITY · PI GONSALVES, GREGG STEVEN · 2019 to 2019
$2.5M
NIAID NIH HHS R01 AI137093NIDA NIH HHS DP2 DA049282NIDA NIH HHS R37 DA015612
6 · The paper itself

Abstract

backgroundIn spring and summer 2022, an outbreak of mpox occurred worldwide, largely confined to men who have sex with men (MSM). There was concern that mpox could break swiftly into congregate settings and populations with high levels of regular frequent physical contact, like university campus communities.

objectiveTo estimate the likelihood of an mpox outbreak and the potential effect of mitigation measures in a residential college setting.

designA stochastic dynamic SEIR (susceptible, exposed but not infectious, infectious, or recovered) model of mpox transmission in a study population was developed, composed of: a high-risk group representative of the population of MSM with a basic reproductive number (

settingU.S. residential college campus.

participantsHypothetical cohort of 6500 students.

interventionIsolation, quarantine, and vaccination of close contacts. MEASUREMENTS: Proportion of 1000 simulations producing sustained transmission; mean cases given sustained transmission; maximum students isolated, quarantined, and vaccinated. All projections are estimated over a planning horizon of 100 days.

resultsWithout mitigation measures, the model estimated an 83% likelihood of sustained transmission, leading to an average of 183 cases. With detection and isolation of 20%, 50%, and 80% of cases, the average infections would fall to 117, 37, and 8, respectively. Reactive vaccination of contacts of detected cases (assuming 50% detection and isolation) reduced mean cases from 37 to 17, assuming 20 vaccinated contacts per detected case. Preemptive vaccination of 50% of the high-risk population before outbreak reduced cases from 37 to 14, assuming 50% detection and isolation. LIMITATION: A model is a stylized portrayal of behavior and transmission on a university campus.

conclusionBased on our current understanding of mpox epidemiology among MSM in the United States, this model-based analysis suggests that future outbreaks of mpox on college campuses may be controlled with timely detection and isolation of symptomatic cases. PRIMARY FUNDING SOURCE: National Institutes of Health National Institute on Drug Abuse and National Institute of Allergy and Infectious Diseases.

Indexed as

COVID-19Mpox, MonkeypoxSexual and Gender MinoritiesHomosexuality, MaleHumansMaleUnited StatesUniversities

Identifiers

PMID36716454
PMCPMC10338074

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.